Skip to content

Weight Loss UAE · 14 min read

Mounjaro in Dubai & the UAE: Results, Dose Steps, Side Effects, Mounjaro vs Ozempic and What to Eat

A doctor's guide to Mounjaro (tirzepatide) for weight loss in Dubai and the UAE: how it works, trial results, dose steps, side effects, who should avoid it, Mounjaro vs Ozempic, counterfeit warnings, a sample day of eating and how to stop without regaining.

Quick answer

Mounjaro (tirzepatide) is a once-weekly prescription injection that copies two gut hormones, GLP-1 and GIP, to reduce appetite and improve blood sugar. In the SURMOUNT-1 trial, adults with obesity lost an average of 15–21% of their body weight over 72 weeks depending on dose, and in the head-to-head SURMOUNT-5 trial tirzepatide gave 20.2% average weight loss versus 13.7% with semaglutide. Treatment starts at 2.5 mg weekly and increases in 2.5 mg steps every four weeks or more, up to 15 mg. Nausea, diarrhoea, constipation and vomiting are common, especially after dose increases. In the UAE, Mounjaro is prescription-only: use it only after a medical assessment, from a licensed pharmacy, with a plan for protein, strength training and maintenance — because weight usually returns after stopping.

Key takeaways

  • Mounjaro is a weekly tirzepatide injection; it is prescription-only in the UAE and counterfeits have been reported.
  • SURMOUNT-1: about 15%, 19.5% and 20.9% average weight loss at 5, 10 and 15 mg over 72 weeks.
  • SURMOUNT-5: tirzepatide 20.2% vs semaglutide 13.7% average weight loss at 72 weeks.
  • In SURMOUNT-4, people switched to placebo regained about 14% of their weight within a year; those who continued lost more.
  • Protein at every meal, strength training and enough fluid in the heat protect muscle and reduce side effects.

Why everyone in Dubai is talking about Mounjaro

Mounjaro is one of the most searched health terms in the UAE. Friends, colleagues and social media show dramatic results, and clinics across Dubai, Abu Dhabi and Sharjah advertise it. For people with obesity, especially with diabetes, it can be life-changing. But it is a prescription medicine with real side effects, and what you eat while using it decides how much of the weight you lose is fat — and whether you keep it off.

This guide explains Mounjaro honestly. It does not replace advice from your own doctor. For the full overview of medicines, read weight loss injections in Dubai, and for the complete UAE program see weight loss in Dubai and the UAE.

How Mounjaro works

Tirzepatide acts on two hormone receptors, GLP-1 and GIP. Together they reduce appetite and 'food noise', slow stomach emptying so you feel full sooner and longer, and help the pancreas release insulin when blood sugar rises. It is injected under the skin once a week, on the same day each week. Mounjaro was first licensed for type 2 diabetes, and the same medicine is licensed for weight management in many countries.

Mounjaro weight loss results in trials

These results come from large trials in which participants also received diet and activity counselling. Individual results vary.

Mounjaro weight loss results in trials
TrialWhoResult
SURMOUNT-1 (72 weeks)Adults with obesity or overweight plus a condition, without diabetes≈ 15% (5 mg), 19.5% (10 mg), 20.9% (15 mg) vs 3.1% placebo
SURMOUNT-5 (72 weeks)Adults with obesity without diabetesTirzepatide 20.2% vs semaglutide 13.7%; waist −18.4 cm vs −13.0 cm
SURMOUNT-4 (after 36 weeks on tirzepatide)People who had already lost about 21%Continuing: further 5.5% loss; switching to placebo: about 14% regain
SURPASS-2 (40 weeks)Adults with type 2 diabetesTirzepatide lowered HbA1c and weight more than semaglutide 1 mg

Mounjaro dose steps

According to the European product information, treatment starts at 2.5 mg once weekly for four weeks — a starting dose to let your body adjust — then increases to 5 mg. Your doctor may increase it in 2.5 mg steps, after at least four weeks on each dose, to 7.5, 10, 12.5 or a maximum of 15 mg. Many people stay on a lower dose if it works and side effects are mild. Never increase the dose yourself, and follow the leaflet for missed doses.

Mounjaro side effects

Most side effects are digestive and are worst after starting or increasing the dose:

  • Common: nausea, diarrhoea, constipation, vomiting, indigestion, bloating, burping, reduced appetite and tiredness. In SURMOUNT-1, nausea affected roughly a quarter to a third of people on the higher doses.
  • Dehydration: vomiting and diarrhoea in UAE heat can strain the kidneys — drink enough fluids.
  • Less common but serious: gallstones, gallbladder inflammation and pancreatitis — severe stomach pain spreading to the back needs urgent care.
  • Low blood sugar: mainly with insulin or sulfonylureas, which may need dose changes.
  • Muscle loss: part of the weight lost can be lean mass without enough protein and strength training.
  • Oral contraceptives: Mounjaro can reduce how well the pill works around the start and dose increases; the product information advises a back-up or non-oral method for four weeks after starting and after each increase.

Free · 2-minute assessment

Get your free UAE weight-loss assessment & personalised plan

  • Your BMI using the right cut-off for your background
  • A realistic first weight-loss target
  • Your daily protein target
  • A personal WhatsApp reply at UAE-friendly times

Step 1 · Your body

Enter your height and weight to see your BMI, healthy weight range and protein target instantly.

Step 2 · Where should Dr. Jai's team send your plan?

Private and seen only by Dr. Jai Vora's team. This assessment is general guidance, not a diagnosis.

Who should not use Mounjaro

It is generally not used in pregnancy, when trying to conceive or while breastfeeding; with a personal or family history of medullary thyroid cancer or MEN2; or after pancreatitis. Extra care is needed with gallbladder disease, severe digestive problems, diabetic eye disease and kidney problems. People with a history of eating disorders need specialist advice. Your doctor will check these before prescribing.

Mounjaro vs Ozempic

Both are weekly injections, but they are different medicines:

Mounjaro vs Ozempic
MounjaroOzempic
Active medicineTirzepatideSemaglutide
Hormones it copiesGLP-1 and GIPGLP-1
Main licenceType 2 diabetes; weight management in many countriesType 2 diabetes (Wegovy is the weight-loss brand of semaglutide)
Average weight loss (obesity trials)Up to ≈ 21% (SURMOUNT-1); 20.2% in SURMOUNT-5≈ 15% with Wegovy 2.4 mg (STEP 1); 13.7% in SURMOUNT-5
Common side effectsNausea, diarrhoea, constipation, vomitingSimilar
After stoppingRegain commonRegain common

Counterfeit Mounjaro: protect yourself

In February 2025, the Department of Health – Abu Dhabi warned the public about counterfeit Ozempic and Mounjaro sold through social media and a website, and reminded residents that both are prescription-only in the UAE. Get a prescription from a UAE-licensed doctor after an assessment, collect the pen from a licensed pharmacy, never buy pens or 'tirzepatide peptides' from Instagram, WhatsApp sellers or websites, and report suspicious products.

What to eat on Mounjaro: a sample day

When appetite drops, every bite must count. Prioritise protein, fibre, fluids and nutrient-dense foods, as a joint advisory from US nutrition and obesity societies recommends. Eat slowly and stop at the first sign of fullness.

What to eat on Mounjaro: a sample day
MealExample (small portions)
Breakfast2 eggs with spinach, or Greek yoghurt with berries — protein first
Mid-morningUnsweetened laban or a protein-rich snack
LunchGrilled chicken or fish (palm-sized), cooked vegetables, 2–3 tbsp rice or ½ small khubz — or dal, sabzi and ½ roti
AfternoonCucumber with 2 tbsp hummus, or 5 almonds
DinnerLentil soup with paneer or chicken, or grilled fish with vegetables
Fluids2.5–3 litres through the day in the heat, sipped between meals

Easing side effects with food

Small meals, eating slowly and stopping when full reduce nausea. Avoid fried, greasy and very spicy food, large portions and fizzy drinks, especially in the days after an injection or dose increase. For constipation, increase vegetables, pulses and fluids gradually. If vomiting or diarrhoea stops you keeping fluids down, contact your doctor. Read more about GLP-1 side effects.

Protect your muscle

Aim for protein at every meal and strength training at least twice a week — squats, push-ups, resistance bands or gym weights. Many people need roughly 1.0–1.5 g of protein per kg of healthy body weight a day; ask your doctor for your target. Read GLP-1 muscle loss and how to prevent it.

Stopping Mounjaro without regaining the weight

SURMOUNT-4 showed that most people regain weight after stopping tirzepatide. If you plan to stop — because of cost, side effects, pregnancy plans or choice — prepare months in advance: build habits that keep calories under control without the medicine, keep protein and strength training, and agree a gradual plan with your doctor. Food-first care before, during and after Mounjaro is where Dr. Jai's program helps most. See natural alternatives to Ozempic and Mounjaro.

Doctor-led nutrition alongside Mounjaro

Dr. Jai Vora is an internal medicine doctor with more than 20 years of experience in food-based weight management. He does not sell injections. He consults online from Mumbai, India, for patients across the UAE and Gulf who are considering, using or coming off Mounjaro, with protein-first meal plans, side-effect strategies and maintenance plans — while your UAE prescribing doctor stays in charge of the medicine. Take the free assessment on this page and mention Mounjaro, or compare with Ozempic in Dubai.

Frequently asked questions

Is Mounjaro available in Dubai?

Mounjaro is a prescription-only medicine in the UAE. It must be prescribed by a licensed doctor after an assessment and dispensed by a licensed pharmacy. Never buy it on social media.

How much weight can you lose on Mounjaro?

In SURMOUNT-1, average weight loss was about 15–21% over 72 weeks depending on dose, alongside diet and activity advice. Results vary widely.

Is Mounjaro better than Ozempic for weight loss?

In the head-to-head SURMOUNT-5 trial, tirzepatide gave 20.2% average weight loss vs 13.7% with semaglutide. The right medicine depends on your health, side effects and your doctor's advice.

What are the most common Mounjaro side effects?

Nausea, diarrhoea, constipation, vomiting and indigestion, mostly after starting or increasing the dose.

What happens when you stop Mounjaro?

Most people regain weight. In SURMOUNT-4, people switched to placebo regained about 14% of their body weight within a year. A food-first maintenance plan before stopping helps.

What should I eat on Mounjaro?

Small meals with protein first, vegetables and pulses for fibre, plenty of fluids, and fewer fried and fatty foods. Strength training twice a week protects muscle.

100% Virtual Clinical Care Worldwide

Get a cellular nutrition plan built on your own reports

Every consultation and diet plan is handled personally by Dr. Jai Vora, by video call and WhatsApp.

References

  1. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205–216. Source
  2. Aronne LJ, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393:26–36. Source
  3. Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA. 2024;331(1):38–48. Source
  4. Frías JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385:503–515. Source
  5. European Medicines Agency. Mounjaro (tirzepatide) — EPAR product information. Source
  6. Department of Health – Abu Dhabi. Circular No. 10/2025: Alert against the use of counterfeit versions of Ozempic and Mounjaro. 4 February 2025. Source
  7. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344–367. Source
  8. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(Suppl 4):16–27. Source
  9. Conte C, Hall KD, Klein S. Is weight loss–induced muscle mass loss clinically relevant? JAMA. 2024;332(1):9–10. Source
  10. Sodhi M, et al. Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA. 2023;330(18):1795–1797. Source
  11. National Institute for Health and Care Excellence. Tirzepatide for managing overweight and obesity (TA1026). Source

This article is for education only. Speak with your doctor before changing medication, diet or treatment.

More from the Weight Loss UAE guide

← All articles